Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Oct 5;20(6):326. doi: 10.3892/ol.2020.12189

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright: © Zhu et al.

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

PMC Copyright notice

Figure 1. — Co-treatment of cisplatin and NVP-BEZ235 synergistically inhibits A549/DDP cell proliferation. (A) Inhibition rates of A549 cells after treatment with cisplatin for 48 h. Inhibition rates of A549/DDP cells after treatment with (B) cisplatin, (C) NVP-BEZ235 and (D) different mass ratios (15:1, 10:1, 5:1, 1:1 or 1:5) of cisplatin and NVP-BEZ235 for 48 h. Data are presented as the mean ± standard deviation (n=3). DDP, diamminedichloroplatinum resistance.